Divi's Laboratories Executive and Leadership Team

Kiran Divi, the Chief Executive Officer at Divi's Laboratories, directs the overarching corporate strategy and long-term vision for the organization. Overseeing the production of generic APIs and complex intermediates, the Chief Executive Officer ensures that manufacturing processes meet stringent global quality standards. Kiran Divi manages the expansion of market reach across international territories, driving competitive advantage through innovation in custom synthesis. By aligning departmental goals with the broader mission of pharmaceutical excellence, the Chief Executive Officer fosters a culture of operational efficiency and technical precision. This leadership role involves constant collaboration with the Board to secure sustainable growth and maintain the company's reputation as a reliable partner in the global healthcare supply chain. Through strategic resource allocation and a focus on high-value product development, the Chief Executive Officer strengthens the market position of the firm within the competitive pharmaceutical landscape.

Kishorebabu Lingamneni, the Chief Financial Officer at Divi's Laboratories, directs all fiscal planning, capital allocation, and financial reporting activities. Overseeing the financial health of the organization, the Chief Financial Officer ensures that investments in manufacturing infrastructure and research initiatives align with corporate profitability targets. Kishorebabu Lingamneni manages risk assessment protocols and maintains transparency with stakeholders regarding the economic performance of the company. This leadership role involves analyzing market trends to inform strategic decisions regarding international expansion and asset management. By implementing robust financial controls and optimizing cost structures, the Chief Financial Officer supports the sustainable growth of the pharmaceutical business. The Chief Financial Officer works closely with the executive team to evaluate the viability of new product launches and capital projects, ensuring that every financial decision reinforces the competitive standing of the firm in the global pharmaceutical market.

Manoranjan Jasti, the Chief Information Officer at Divi's Laboratories, directs the digital transformation and technological infrastructure necessary for modern pharmaceutical manufacturing. Overseeing the integration of advanced data analytics and secure information systems, the Chief Information Officer ensures that manufacturing processes remain efficient and compliant with global data standards. Manoranjan Jasti manages the cybersecurity framework to protect proprietary research and sensitive operational data across all regional facilities. This leadership role involves deploying scalable software solutions that streamline communication between production units and corporate headquarters. By leveraging technology to enhance supply chain visibility and operational transparency, the Chief Information Officer drives productivity improvements throughout the organization. The Chief Information Officer collaborates with other executives to implement digital tools that support rapid decision-making and long-term innovation, ensuring that the technological backbone of the company remains robust and capable of supporting future expansion.

Murali Divi, the Managing Director at Divi's Laboratories, oversees the foundational operational framework and technical manufacturing capabilities of the company. Managing Director Murali Divi drives the development of advanced chemical processes required for the synthesis of nutraceutical ingredients and pharmaceutical intermediates. This role involves direct supervision of large-scale manufacturing facilities to ensure consistent output and adherence to international regulatory requirements. By architecting complex supply chain solutions, the Managing Director optimizes production cycles and reduces lead times for global clients. The Managing Director maintains close coordination with research and development teams to integrate new scientific advancements into existing product lines. Through a commitment to technical excellence and process optimization, the Managing Director secures the operational integrity of the firm, ensuring that all manufacturing activities support the long-term commercial objectives and market leadership of the organization.